- Underlying: CVNA
- View: Bullish momentum, but with RSI overbought suggesting near-term consolidation/pullback risk before a potential move higher. We aim to capture upside to resistance while defining risk.
- Strategy Type: Debit Spread / Directional
- Option Contract Portfolio:
- Buy 1 CVNA May 1, 2026 $400 Call
- Sell 1 CVNA May 1, 2026 $425 Call
- Max Gain & Loss: Max Gain = $2,500 per spread; Max Loss = Net Debit Paid ($1,150 per spread, estimated).
- Initial Cost/Credit: Debit of ~$11.50 per share ($1,150 per 100-share spread).
- Greek Exposure (Simulated):
- Delta: +0.15 (Moderate Positive, bullish)
- Theta: -$0.10 per day (Slightly negative, but lower than a long call due to short leg)
- Vega: +0.01 (Low Positive, benefits slightly from IV increase)
- Gamma: ~0.005 (Low)
- Rho: ~0.04 (Low Positive)
- Rationale: This strategy aligns with a "cautiously optimistic" view. It offers a cost-effective way to position for a move towards the $425-$435 resistance zone. The long call at $400 provides upside participation, while selling the $425 call reduces the initial premium outlay (debit) and defines maximum profit at $425. It balances Delta (direction) with cost control. Profit is maximized if CVNA is at or above $425 at expiration. The negative Theta is mitigated compared to a naked long call.
- Time Frame: Short-term (Expiry: ~10 days).
Comments